On Friday, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) was -3.73% drop from the session before, before settling in for the closing price of $1.61. A 52-week range for IRWD has been $0.53 – $5.13.
Annual sales at Healthcare sector company slipped by -47.49% over the past five years. When this article was written, the company’s average yearly earnings per share was at 1815.20%. With a float of $156.35 million, this company’s outstanding shares have now reached $162.43 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ironwood Pharmaceuticals Inc stocks. The insider ownership of Ironwood Pharmaceuticals Inc is 3.74%, while institutional ownership is 90.40%. The most recent insider transaction that took place on Aug 11 ’25, was worth 1,105. In this transaction Chief Commercial Officer of this company sold 1,316 shares at a rate of $0.84, taking the stock ownership to the 241,280 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Legal Officer sold 7,754 for $0.84, making the entire transaction worth $6,513. This insider now owns 400,378 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.02 earnings per share (EPS) during the time that was less than consensus figure (set at 0.1) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1815.20% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
You can see what Ironwood Pharmaceuticals Inc (IRWD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.82. Likewise, its price to free cash flow for the trailing twelve months is 8.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) saw its 5-day average volume 1.61 million, a negative change from its year-to-date volume of 2.61 million. As of the previous 9 days, the stock’s Stochastic %D was 78.60%.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 85.04%, which indicates a significant increase from 61.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1403 in the past 14 days, which was higher than the 0.0910 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1579, while its 200-day Moving Average is $1.5412. Nevertheless, the first resistance level for the watch stands at $1.7166 in the near term. At $1.8832, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0365. If the price goes on to break the first support level at $1.3967, it is likely to go to the next support level at $1.2434. The third support level lies at $1.0768 if the price breaches the second support level.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
There are 162,434K outstanding shares of the company, which has a market capitalization of 251.77 million. As of now, sales total 351,410 K while income totals 880 K. Its latest quarter income was 85,240 K while its last quarter net income were 23,600 K.
